MedTrace Logo

Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus

NCT04176887 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-11-25

No results posted yet for this study

Summary

The study will be conducted on 60 children suffering from status epilepticus who will be admitted to Pediatric Neurology Unit and Pediatric ICU of Tanta Hospital University.

Conditions

  • Comparison
  • the Efficacy of Levetireacetam
  • Phenytoin
  • Management of Pediatric Status Epilepticus

Interventions

DRUG

Levetiracetam Injection

The levetiracetam dose is 20- 40 mg/kg by intravenous infusion over 15 minute, a rate of 2-5 mg/kg/minute diluted in 100 ml with 0.9% sodium chloride as a single dose.

DRUG

Phenytoin Injection

Phenytoin dose is 20-40 mg/kg/min by intravenous infusion over 30 minute, diluted with 0.9% sodium chloride to a maximum concentration of 10 mg/ml.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Amira Darwish, MD · Tanta University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-02-01
Completion
2020-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04176887 on ClinicalTrials.gov